Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines
Maurizio Chiriva-Internati, Everardo Cobos, Diane M. Da Silva and W. Martin Kast
Cancer Immunity 8 : 8 (24 April 2008) >Abstract >Full text

An unusual case of metastatic melanoma sensitive to chemotherapy and immunotherapy, with late immune escape in the brain
Verena Voelter, Alessia Pica, Julien Laurent, Donata Rimoldi, Hanifa Bouzourene, Ali Sajadi, Maurice Matter, Pedro Romero, Nathalie Rufer and Daniel E. Speiser
Cancer Immunity 8 : 6 (27 March 2008) >Full text

Cancer Vaccines 2005: Closing remarks
Kunle Odunsi
Cancer Immunity 6 Suppl 1 : 24 (6 February 2006) >Full text

Withdrawal of immunosuppression contributing to the remission of malignant melanoma: a case report
F. Stephen Hodi, Scott Granter, and Joseph Antin
Cancer Immunity 5 : 7 (19 May 2005) >Full text

Cancer Vaccines 2004 opening address: The molecular and cellular basis of cancer immunosurveillance and immunoediting
Robert D. Schreiber
Cancer Immunity 5 Suppl 1 : 1 (6 April 2005) >Full text

The uterine cervix - a new member of the family of immunologically exceptional sites?
Petter Höglund, Klas Kärre, and Georg Klein
Cancer Immunity 3 : 6 (7 July 2003) >Abstract >Full text

Cancer Vaccine Collaborative 2002: Opening address
Lloyd J. Old
Cancer Immunity 3 Suppl 1 : 1 (6 February 2003) >Full text

Cancer Vaccines 2003: Opening address
Lloyd J. Old
Cancer Immunity 3 Suppl 2 : 1 (12 December 2003) >Full text

Can hTERT peptide540-548-specific CD8 T cells recognize and kill tumor cells?
Daniel E. Speiser, Jean-Charles Cerottini, and Pedro Romero
Cancer Immunity 2 : 14 (14 October 2002) >Full text

Towards a Cancer Immunome Database
Victor Jongeneel
Cancer Immunity 1 : 3 (30 March 2001) >Full text